CRISPR Therapeutics AG - Common Shares (CRSP)
41.46
+0.29 (0.70%)
Crispr Therapeutics is a biopharmaceutical company that focuses on developing transformative gene-based medicines for serious diseases using its proprietary CRISPR/Cas9 gene editing technology
The company aims to harness the potential of genetic editing to treat various conditions, including genetic disorders, cancer, and autoimmune diseases. Through a combination of innovative research and strategic collaborations, Crispr Therapeutics is dedicated to advancing its pipeline of therapies and ultimately improving patient outcomes and quality of life.
| Previous Close | 41.17 |
|---|---|
| Open | 40.71 |
| Bid | 41.42 |
| Ask | 41.50 |
| Day's Range | 40.41 - 41.53 |
| 52 Week Range | 36.52 - 75.91 |
| Volume | 675,532 |
| Market Cap | 3.27B |
| PE Ratio (TTM) | -9.531 |
| EPS (TTM) | -4.4 |
| Dividend & Yield | N/A (N/A) |
| 1 Month Average Volume | 2,074,179 |
